Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Arsenic and Ayurveda

J Treleaven1, S Meller, P Farmer

  • 1Royal Marsden Hospital, Sutton, Surrey, England, UK.

Leukemia & Lymphoma
|July 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Results from a phase Ib study of telisotuzumab vedotin in combination with osimertinib in patients with c-Met protein-overexpressing, EGFR-mutated locally advanced/metastatic non-small-cell lung cancer (NSCLC) after progression on prior osimertinib.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Thrombogenicity of biodegradable metals.

Bioactive materials·2024
Same author

Long-term survival with first-line nivolumab plus ipilimumab in patients with advanced non-small-cell lung cancer: a pooled analysis.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Absence of damaging effects of stem cell donation in unrelated donors assessed by FISH and gene variance screening.

Bone marrow transplantation·2020
Same author

Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2020
Same author

Trainee radiologist reports as a source of confirmation bias in radiology.

Clinical radiology·2018
Same journal

Leukemia mortality analysis in the pediatric population in São Paulo state, Brazil, 2000-2019.

Leukemia & lymphoma·2026
Same journal

CPX‑351 vs. FLAG‑ida in patients with high-risk AML/MDS and MDS-related gene mutations: a subgroup analysis of the UK NCRI AML19 trial.

Leukemia & lymphoma·2026
Same journal

Specialist palliative care access and end-of-life hospitalizations in acute leukemia: a nationwide register study.

Leukemia & lymphoma·2026
Same journal

D-VRD vs. D-KRD induction in transplant-eligible multiple myeloma: a real-world comparison.

Leukemia & lymphoma·2026
Same journal

T-box factor EOMES is part of an aberrant network in Hodgkin lymphoma.

Leukemia & lymphoma·2026
Same journal

Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population.

Leukemia & lymphoma·2026
See all related articles

An Ayurvedic arsenic compound, used in India for blood disorders, shows efficacy in managing haematological malignancies. This traditional remedy

Area of Science:

  • Ayurvedic medicine
  • Hematology
  • Toxicology

Background:

  • Traditional Ayurvedic medicine utilizes arsenic compounds for therapeutic purposes.
  • Arsenic has a historical precedent in Western medicine for treating blood disorders, notably chronic myeloid leukemia over a century ago.

Observation:

  • An arsenic-containing Ayurvedic compound is currently manufactured and used in India.
  • This compound is administered to patients diagnosed with haematological malignancies.

Findings:

  • The study evaluates the efficacy of the Ayurvedic arsenic compound in controlling blood counts.
  • The research also assesses the side effects associated with the compound's use.

Implications:

  • This work bridges traditional Indian medicine with modern hematological treatment approaches.

Related Experiment Videos

  • Understanding the efficacy and safety of this arsenic compound could inform future therapeutic strategies for blood cancers.